Assessment and treatment of the withdrawal syndrome in paediatric intensive care units: Systematic review.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
entrez:
1
2
2020
pubmed:
1
2
2020
medline:
14
2
2020
Statut:
ppublish
Résumé
Sedoanalgesia secondary iatrogenic withdrawal syndrome (IWS) in paediatric intensive units is frequent and its assessment is complex. Therapies are heterogeneous, and there is currently no gold standard method for diagnosis. In addition, the assessment scales validated in children are scarce. This paper aims to identify and describe both the paediatric diagnostic and assessment tools for the IWS and the treatments for the IWS in critically ill paediatric patients. A systematic review was conducted according to the PRISMA guidelines. This review included descriptive and observational studies published since 2000 that analyzed paediatric scales for the evaluation of the iatrogenic withdrawal syndrome and its treatments. The eligibility criteria included neonates, newborns, infants, pre-schoolers, and adolescents, up to age 18, who were admitted to the paediatric intensive care units with continuous infusion of hypnotics and/or opioid analgesics, and who presented signs or symptoms of deprivation related to withdrawal and prolonged infusion of sedoanalgesia. Three assessment scales were identified: Withdrawal Assessment Tool-1, Sophia Observation Withdrawal Symptoms, and Opioid and Benzodiazepine Withdrawal Score. Dexmedetomidine, methadone and clonidine were revealed as options for the treatment and prevention of the iatrogenic withdrawal syndrome. Finally, the use of phenobarbital suppressed symptoms of deprivation that are resistant to other drugs. The reviewed scales facilitate the assessment of the iatrogenic withdrawal syndrome and have a high diagnostic quality. However, its clinical use is very rare. The treatments identified in this review prevent and effectively treat this syndrome. The use of validated iatrogenic withdrawal syndrome assessment scales in paediatrics clinical practice facilitates assessment, have a high diagnostic quality, and should be encouraged, also ensuring nurses' training in their usage.
Sections du résumé
BACKGROUND
BACKGROUND
Sedoanalgesia secondary iatrogenic withdrawal syndrome (IWS) in paediatric intensive units is frequent and its assessment is complex. Therapies are heterogeneous, and there is currently no gold standard method for diagnosis. In addition, the assessment scales validated in children are scarce. This paper aims to identify and describe both the paediatric diagnostic and assessment tools for the IWS and the treatments for the IWS in critically ill paediatric patients.
METHODS
METHODS
A systematic review was conducted according to the PRISMA guidelines. This review included descriptive and observational studies published since 2000 that analyzed paediatric scales for the evaluation of the iatrogenic withdrawal syndrome and its treatments. The eligibility criteria included neonates, newborns, infants, pre-schoolers, and adolescents, up to age 18, who were admitted to the paediatric intensive care units with continuous infusion of hypnotics and/or opioid analgesics, and who presented signs or symptoms of deprivation related to withdrawal and prolonged infusion of sedoanalgesia.
RESULTS
RESULTS
Three assessment scales were identified: Withdrawal Assessment Tool-1, Sophia Observation Withdrawal Symptoms, and Opioid and Benzodiazepine Withdrawal Score. Dexmedetomidine, methadone and clonidine were revealed as options for the treatment and prevention of the iatrogenic withdrawal syndrome. Finally, the use of phenobarbital suppressed symptoms of deprivation that are resistant to other drugs.
CONCLUSIONS
CONCLUSIONS
The reviewed scales facilitate the assessment of the iatrogenic withdrawal syndrome and have a high diagnostic quality. However, its clinical use is very rare. The treatments identified in this review prevent and effectively treat this syndrome. The use of validated iatrogenic withdrawal syndrome assessment scales in paediatrics clinical practice facilitates assessment, have a high diagnostic quality, and should be encouraged, also ensuring nurses' training in their usage.
Identifiants
pubmed: 32000360
doi: 10.1097/MD.0000000000018502
pii: 00005792-202001310-00007
pmc: PMC7004796
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e18502Références
Crit Care Med. 2017 Jan;45(1):e7-e15
pubmed: 27513532
Glob Adv Health Med. 2013 Sep;2(5):38-43
pubmed: 24416692
Crit Care Med. 2014 Jul;42(7):1592-600
pubmed: 24717461
Med Intensiva. 2013 Mar;37(2):67-74
pubmed: 22608303
Pediatr Crit Care Med. 2000 Oct;1(2):119-23
pubmed: 12813261
Crit Care Med. 2005 Sep;33(9):2110-2
pubmed: 16148487
Physiol Res. 2016 Dec 21;65(Supplementum 4):S463-S472
pubmed: 28006928
Ann Pharmacother. 2009 Sep;43(9):1506-11
pubmed: 19690220
J Pediatr Intensive Care. 2012 Mar;1(1):5-15
pubmed: 31214379
Intensive Care Med. 2006 Aug;32(8):1125-36
pubmed: 16699772
Pediatr Crit Care Med. 2015 Feb;16(2):175-83
pubmed: 25560429
BMJ Open. 2015 Mar 30;5(3):e006428
pubmed: 25823444
An Pediatr (Barc). 2011 Jun;74(6):396-404
pubmed: 21353654
Paediatr Anaesth. 2009 Jul;19 Suppl 1:166-79
pubmed: 19572854
Pediatr Crit Care Med. 2013 Oct;14(8):761-9
pubmed: 23962832
Intensive Crit Care Nurs. 2004 Dec;20(6):344-51
pubmed: 15567675
Paediatr Anaesth. 2003 Nov;13(9):805-10
pubmed: 14617122
J Clin Anesth. 2013 Feb;25(1):62-5
pubmed: 23246494
Pain. 2012 Jan;153(1):142-8
pubmed: 22093817
Pharmacotherapy. 2012 Feb;32(2):148-57
pubmed: 22392424
Intensive Care Med. 2007 Aug;33(8):1396-406
pubmed: 17541548
J Intensive Care Med. 2007 May-Jun;22(3):173-9
pubmed: 17569173
JAMA. 2015 Jan 27;313(4):379-89
pubmed: 25602358
Pediatr Crit Care Med. 2011 Sep;12(5):504-11
pubmed: 21076361
Intensive Care Med. 2016 Jun;42(6):972-86
pubmed: 27084344
Ann Intensive Care. 2017 Dec;7(1):36
pubmed: 28341980
J Opioid Manag. 2006 Jul-Aug;2(4):201-5
pubmed: 17319480
J Pediatr Pharmacol Ther. 2015 Jan-Feb;20(1):45-53
pubmed: 25859170
Pediatrics. 2010 May;125(5):e1208-25
pubmed: 20403936
Crit Care Med. 2000 Jun;28(6):2122-32
pubmed: 10890677
Med Clin (Barc). 2010 Oct 9;135(11):507-11
pubmed: 20206945
Heart Lung. 2013 May-Jun;42(3):171-6
pubmed: 23643411
Pediatr Crit Care Med. 2008 Nov;9(6):573-80
pubmed: 18838937
Heart Lung. 2013 Nov-Dec;42(6):407-13
pubmed: 24008186
Ann Pharmacother. 2003 Apr;37(4):473-7
pubmed: 12659598
Crit Care Med. 2008 Aug;36(8):2427-32
pubmed: 18596622
Pharmacotherapy. 2001 Dec;21(12):1566-73
pubmed: 11765307